42
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Influence of Tumor Peroxisome Proliferator-Activated Receptor γ and δ Expression on Postoperative Mortality of Patients Undergoing Colorectal Cancer Surgery

, MD, , MD, , MD, , MD, , MD, , MD & , MD show all
Pages 105-111 | Received 23 Jul 2008, Accepted 02 Dec 2008, Published online: 09 Jul 2009

REFERENCES

  • Ajiki W, Tsukuma H, Oshima A, et al. Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol 2004; 34: 352–356
  • Chao A, Thun M J, Connell C J, et al. Meat consumption and risk of colorectal cancer. JAMA 2005; 293: 172–182
  • Kuriki K, Hirose K, Matsuo K, et al. Meat, milk, saturated fatty acids, the Pro12Ala and C161T polymorphisms of the PPARgamma gene and colorectal cancer risk in Japanese. Cancer Sci 2006; 97: 1226–1235
  • Meyerhardt J A, Niedzwiecki D, Hollis D, et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA 2007; 298: 754–764
  • Koeffler H P. Peroxisome proliferator-activated receptor gamma and cancers. Clin Cancer Res 2003; 9: 1–9
  • Issemann I, Prince R A, Tugwood J D, et al. The peroxisome proliferator-activated receptor: retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J Mol Endocrinol 1993; 11: 37–47
  • Lefebvre M, Paulweber B, Fajas L, et al. Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells. J Endocrinol 1999; 162: 331–340
  • Gupta R A, Dubois R N. Controversy: PPARgamma as a target for treatment of colorectal cancer. Am J Physiol Gastrointest Liver Physiol 2002; 283: 266–269
  • Osawa E, Nakajima A, Wada K, et al. Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice. Gastroenterology 2003; 124: 361–367
  • Rumi M A, Ishihara S, Kazumori H, et al. Can PPAR gamma ligands be used in cancer therapy?. Curr Med Chem Anticancer Agents 2004; 4: 465–477
  • Cesario R M, Stone J, Yen W C, et al. Differentiation and growth inhibition mediated via the RXR: PPARgamma heterodimer in colon cancer. Cancer Lett 2006; 240: 225–233
  • Kitamura S, Miyazaki Y, Shinomura Y, et al. Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells. Jpn J Cancer Res 1999; 90: 75–80
  • Lu J, Imamura K, Nomura S, et al. Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice. Cancer Res 2005; 65: 4769–4774
  • Harman F S, Nicol C J, Marin H E, et al. Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis. Nat Med 2004; 10: 481–483
  • Takayama O, Yamamoto H, Damdinsuren B, et al. Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology. Br J Cancer 2006; 95: 889–895
  • Linsalata M, Giannini R, Notarnicola M, et al. Peroxisome proliferator-activated receptor gamma and spermidine/spermine N1-acetyltransferase gene expressions are significantly correlated in human colorectal cancer. BMC Cancer 2006; 6: 191
  • Theocharis S, Giaginis C, Parasi A, et al. Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: correlation with histopathological parameters, cell cycle-related molecules, and patients' survival. Dig Dis Sci 2007; 52: 2305–2311
  • Yang L, Zhou Z G, Luo H Z, et al. Quantitative analysis of PPARdelta mRNA by real-time RT-PCR in 86 rectal cancer tissues. Eur J Surg Oncol 2006; 32: 181–185
  • Sarraf P, Mueller E, Smith W M, et al. Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol Cell 1999; 3: 799–804
  • Marin H E, Peraza M A, Billin A N, et al. Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis. Cancer Res 2006; 66: 4394–4401
  • Gupta R A, Tan J, Krause W F, et al. Prostacyclin-mediated activation of PPAR delta in colorectal cancer. Proc Natl Acad Sci USA 2000; 97: 13275–13280
  • He T C, Chan T A, Vogelstein B, et al. PPAR delta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 1999; 99: 335–345
  • Park B H, Vogelstein B, Kinzler K W, et al. Genetic disruption of PPAR delta decreases the tumorigenicity of human colon cancer cells. Proc Natl Acad Sci USA 2001; 98: 2598–2603
  • Yang L, Zhou Z G, Zhang X L, et al. RNA interference against peroxisome proliferator-activated receptor delta gene promotes proliferation of human colorectal cancer cells. Dis Colon Rectum 2008; 51: 318–326
  • Xu F, Wang F, Di M, et al. Classification based on the combination of molecular and pathologic predictors is superior to molecular classification on prognosis in colorectal carcinoma. Clin Cancer Res 2007; 13: 5082–5088

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.